# CENTERA-2: Safety and Performance Study of the Edwards CENTERA-EU Self-Expanding Transcatheter Heart Valve

> **NCT02458560** · NA · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 203 (actual)

## Conditions studied

- Aortic Valve Disease

## Interventions

- **DEVICE:** Edwards CENTERA Self-Expanding Transcatheter Heart Valve

## Key facts

- **NCT ID:** NCT02458560
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-08-22
- **Final completion:** 2021-08-13
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2021-10-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02458560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02458560, "CENTERA-2: Safety and Performance Study of the Edwards CENTERA-EU Self-Expanding Transcatheter Heart Valve". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02458560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*